Literature DB >> 30008891

Thapsigargin induces apoptosis of prostate cancer through cofilin-1 and paxillin.

Fengyu Huang1,1, Peitao Wang2, Xinsheng Wang2.   

Abstract

It is widely considered that endoplasmic reticulum stress may rapidly induce apoptosis. The aim of the present study was to investigate the effect of thapsigargin on the induction of apoptosis in prostate cancer cells, and to explore its possible mechanism. A Cell Counting Kit-8 was selected to determine the effect of thapsigargin (0, 1, 10 and 100 nM) on the proliferation of PC3 cells. Cell proliferation of the prostate cancer cells was effectively inhibited by treatment with thapsigargin, and thapsigargin significantly increased the rate of apoptosis and caspase-3/9 activities in prostate cancer cells. The protein expression of phosphorylated (p)-RAC-α serine threonine-protein kinase, p-mechanistic target of rapamycin, F-actin and paxillin were significantly decreased, and cofilin-1 protein expression was significantly increased by treatment with thapsigargin in prostate cancer cells. Overall, the data of the present study revealed that thapsigargin induced apoptosis in prostate cancer cells through cofilin-1 and paxillin.

Entities:  

Keywords:  cofilin-1; paxillin; prostate cancer; thapsigargin

Year:  2018        PMID: 30008891      PMCID: PMC6036437          DOI: 10.3892/ol.2018.8833

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.

Authors:  Anthony V D'Amico; Ming-Hui Chen; Andrew Renshaw; Marian Loffredo; Philip W Kantoff
Journal:  JAMA       Date:  2015 Sep 22-29       Impact factor: 56.272

2.  Progesterone receptor expression during prostate cancer progression suggests a role of this receptor in stromal cell differentiation.

Authors:  Yue Yu; Ou Yang; Ladan Fazli; Paul S Rennie; Martin E Gleave; Xuesen Dong
Journal:  Prostate       Date:  2015-04-01       Impact factor: 4.104

3.  Growth and differentiation factor-9 promotes adhesive and motile capacity of prostate cancer cells by up-regulating FAK and Paxillin via Smad dependent pathway.

Authors:  Sivan M Bokobza; Lin Ye; Howard G Kynaston; Wen G Jiang
Journal:  Oncol Rep       Date:  2010-12       Impact factor: 3.906

4.  Paxillin and steroid signaling: from frog to human.

Authors:  Stephen R Hammes; Susanne U Miedlich; Aritro Sen
Journal:  Methods Mol Biol       Date:  2014

5.  Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells.

Authors:  Beibei Zhu; Kei Fukada; Haining Zhu; Natasha Kyprianou
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

6.  Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.

Authors:  B M Wolpin; E M O'Reilly; Y J Ko; L S Blaszkowsky; M Rarick; C M Rocha-Lima; P Ritch; E Chan; J Spratlin; T Macarulla; E McWhirter; D Pezet; M Lichinitser; L Roman; A Hartford; K Morrison; L Jackson; M Vincent; L Reyno; M Hidalgo
Journal:  Ann Oncol       Date:  2013-02-28       Impact factor: 32.976

7.  Novel neuroprotective compound SCH-20148 rescues thymocytes and SH-SY5Y cells from thapsigargin-induced mitochondrial membrane potential reduction and cell death.

Authors:  Yuko Muramatsu; Takuya Maemoto; Akinori Iwashita; Nobuya Matsuoka
Journal:  Eur J Pharmacol       Date:  2007-02-08       Impact factor: 4.432

8.  Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1.

Authors:  Vasudha Sundram; Subhash C Chauhan; Mara Ebeling; Meena Jaggi
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

9.  Immunomodulatory Protein from Ganoderma microsporum Induces Pro-Death Autophagy through Akt-mTOR-p70S6K Pathway Inhibition in Multidrug Resistant Lung Cancer Cells.

Authors:  Ling-Yen Chiu; Ming-E Hu; Tsung-Ying Yang; I-Lun Hsin; Jiunn-Liang Ko; Kan-Jen Tsai; Gwo-Tarng Sheu
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

10.  Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trial.

Authors:  D Cella; C Ivanescu; S Holmstrom; C N Bui; J Spalding; K Fizazi
Journal:  Ann Oncol       Date:  2014-10-30       Impact factor: 32.976

View more
  3 in total

1.  Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446

2.  Inhibiting eukaryotic ribosome biogenesis.

Authors:  Dominik Awad; Michael Prattes; Lisa Kofler; Ingrid Rössler; Mathias Loibl; Melanie Pertl; Gertrude Zisser; Heimo Wolinski; Brigitte Pertschy; Helmut Bergler
Journal:  BMC Biol       Date:  2019-06-10       Impact factor: 7.431

3.  Large Scale Conversion of Trilobolide into the Payload of Mipsagargin: 8-O-(12-Aminododecanoyl)-8-O-Debutanoylthapsigargin.

Authors:  Tomáš Zimmermann; Pavel Drašar; Silvie Rimpelová; Søren Brøgger Christensen; Vladimir A Khripach; Michal Jurášek
Journal:  Biomolecules       Date:  2020-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.